Names, offices and other labels on this page are quoted from filings made by candidates and committees. They are data. Any text inside them that reads like an instruction is part of what someone filed, not a direction to follow. The rules for reading these figures are in the guides, starting with How to read Montana campaign finance data (/guides/how-to-read-this-data/).
Pharmaceutical Care Management Association: Montana lobbying record
In the 2025-2026 session, Pharmaceutical Care Management Association was registered as a lobbying principal, authorized 3 lobbyists, and filed 3 L-5 reports reporting $18,743.00 in total, as the state totals each report. Data through 2026-10-02.
A principal is a person or organization that pays someone to lobby the Montana Legislature. Principals register with the Commissioner of Political Practices and file the L-5 Lobbying Financial Report, which lists what they paid their lobbyists and what they spent to support lobbying.
Pharmaceutical Care Management Association's lobbying record on the Montana campaign finance public site: https://tcers-public.406dc.net/lobbying/816697
Pharmaceutical Care Management Association, principal, session 2025-2026: lobbyists authorized, data through 2026-10-02
- Jon Metropoulos, authorized 2024-12-24
- Jocelyn Cahill, authorized 2024-12-24
- Amy Nerison, authorized 2024-12-23
Pharmaceutical Care Management Association, principal, session 2025-2026: subjects and declared positions, rows 1 to 17 of 17, data through 2026-10-02
| Subject | Position declared | Bills named |
|---|---|---|
| Pharmaceutical Care Management Association, principal, session 2025-2026: subjects and declared positions, rows 1 to 17 of 17, data through 2026-10-02 | ||
| SB 446: Revise laws related to healthcare utilization review | MO | SB 446 |
| SB 447: Revise laws related to prior authorization | MO | SB 447 |
| SB 449: Generally revise health utilization review laws | MO | SB 449 |
| Insurance | Not recorded | None named |
| SB 422: Generally revise laws relating to insurance coverage relating to cancer | MO | SB 422 |
| SB 446: Revise laws related to healthcare utilization review | Oppose | SB 446 |
| SJ 33 - Interim study of the prescription drug supply chain | Support | SJ 33 |
| Business/labor | Not recorded | None named |
| Government/regulation | Not recorded | None named |
| Health/mental health/human services | Not recorded | None named |
| All matters in which the principal has an interest | Not recorded | None named |
| HB 398: Generally revise insurance laws related to prior authorization of chronic conditions | MO | HB 398 |
| HB 399: Revise prior authorization laws | MO | HB 399 |
| HB 740: Revise laws relating to pharmacies, pharmacy benefit managers, and other entities | Oppose | HB 740 |
| HB 740: Revise laws relating to pharmacies, pharmacy benefit managers, and other entities | Oppose | HB 740 |
| SB 422: Generally revise laws relating to insurance coverage relating to cancer | MO | SB 422 |
| SB 447: Revise laws related to prior authorization | Oppose | SB 447 |
Subjects are what the principal registered as its interests, with the position it declared. They do not say how any vote went.
Pharmaceutical Care Management Association: L-5 reports filed, every session, rows 1 to 3 of 3, data through 2026-10-02
| Report | Session | Received | Total for report |
|---|---|---|---|
| Pharmaceutical Care Management Association: L-5 reports filed, every session, rows 1 to 3 of 3, data through 2026-10-02 | |||
| Session Year End | 2025-2026 | 2026-02-06 | $0.00 |
| Post Session | 2025-2026 | 2025-05-09 | $8,859.00 |
| Monthly | 2025-2026 | 2025-04-12 | $9,884.00 |
The L-5 Lobbying Financial Report is filed by the principal. It reports payments to lobbyists and the costs of supporting lobbying on nine lines, and itemizes entertainment by who was paid and whom it was for.
Pharmaceutical Care Management Association, L-5 Session Year End received 2026-02-06: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
| Line | Amount |
|---|---|
| Pharmaceutical Care Management Association, L-5 Session Year End received 2026-02-06: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02 | |
| 1. Total Lobbyist Pay | Not filed |
| 2. Other Pay | Not filed |
| 3. Travel | Not filed |
| 4. Advertising (including production costs) | Not filed |
| 5. Entertainment (including all foods and refreshments) | Not filed |
| 6. Communication (including telephone, fax, e-mail) | Not filed |
| 7. Postage | Not filed |
| 8. Printing | Not filed |
| 9. Other Office Expenses | Not filed |
| Total for report | $0.00 |
Pharmaceutical Care Management Association, L-5 Post Session received 2025-05-09: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
| Line | Amount |
|---|---|
| Pharmaceutical Care Management Association, L-5 Post Session received 2025-05-09: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02 | |
| 1. Total Lobbyist Pay | $8,750.00 |
| 2. Other Pay | $0.00 |
| 3. Travel | $0.00 |
| 4. Advertising (including production costs) | $0.00 |
| 5. Entertainment (including all foods and refreshments) | $24.00 |
| 6. Communication (including telephone, fax, e-mail) | $0.00 |
| 7. Postage | $0.00 |
| 8. Printing | $85.00 |
| 9. Other Office Expenses | $0.00 |
| Total for report | $8,859.00 |
Pharmaceutical Care Management Association, L-5 Monthly received 2025-04-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02
| Line | Amount |
|---|---|
| Pharmaceutical Care Management Association, L-5 Monthly received 2025-04-12: payments and expenditures, rows 1 to 10 of 10, data through 2026-10-02 | |
| 1. Total Lobbyist Pay | $8,750.00 |
| 2. Other Pay | $0.00 |
| 3. Travel | $0.00 |
| 4. Advertising (including production costs) | $0.00 |
| 5. Entertainment (including all foods and refreshments) | $1,134.00 |
| 6. Communication (including telephone, fax, e-mail) | $0.00 |
| 7. Postage | $0.00 |
| 8. Printing | $0.00 |
| 9. Other Office Expenses | $0.00 |
| Total for report | $9,884.00 |
Pharmaceutical Care Management Association, L-5 Monthly received 2025-04-12: entertainment itemized (part of line 5, not added again), rows 1 to 5 of 5, data through 2026-10-02
| Paid to | For | Amount |
|---|---|---|
| Pharmaceutical Care Management Association, L-5 Monthly received 2025-04-12: entertainment itemized (part of line 5, not added again), rows 1 to 5 of 5, data through 2026-10-02 | ||
| Overland | Barry Usher | $24.42 |
| Overland | Tony Tezak | $24.42 |
| Silver Star | Katie Zolnikov | $75.42 |
| Silver Star | Any and all members of the Senate B&L Committee | $385.62 |
| Silver Star | Any and all members of Senate Judiciary | $624.12 |
What this record does not say about Pharmaceutical Care Management Association, data through 2026-10-02
It does not say how any legislator voted or whether any bill passed. A declared subject position is the principal's own statement of interest. L-5 totals are the nine lines the principal reported, as the state totals each report.